The Hong Kong Practitioner

Table 3: Important reasons affecting choice of prescribed antihypertensives in patients without concomitant cardiovascular risk factors

Basic trainees
(Number / %)

Higher trainees
(Number / %)

(A)

Best tolerability profiles

43 / 57%

11 / 44%

(B)

Best effectiveness profiles

35 / 46%

13 / 52%

(C)

Cost consideration

15 / 20%

5 / 20%

(D)

Administrative

15 / 20%

4 / 16%

(E)

Anticipated patient compliance

19 / 25%

9 / 36%

(F)

Usual prescription practice

16 / 21%

7 / 28%

(G)

Others Nil Nil

(Note:

Participants can choose, among (A) to (G), a maximum of 2 responses, or none.)